Cite
Delineating the autistic phenotype in children with neurofibromatosis type 1.
MLA
Chisholm, Anita K., et al. “Delineating the Autistic Phenotype in Children with Neurofibromatosis Type 1.” Molecular Autism, vol. 13, no. 1, Jan. 2022, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s13229-021-00481-3.
APA
Chisholm, A. K., Haebich, K. M., Pride, N. A., Walsh, K. S., Lami, F., Ure, A., Maloof, T., Brignell, A., Rouel, M., Granader, Y., Maier, A., Barton, B., Darke, H., Dabscheck, G., Anderson, V. A., Williams, K., North, K. N., & Payne, J. M. (2022). Delineating the autistic phenotype in children with neurofibromatosis type 1. Molecular Autism, 13(1), 1–17. https://doi.org/10.1186/s13229-021-00481-3
Chicago
Chisholm, Anita K., Kristina M. Haebich, Natalie A. Pride, Karin S. Walsh, Francesca Lami, Alex Ure, Tiba Maloof, et al. 2022. “Delineating the Autistic Phenotype in Children with Neurofibromatosis Type 1.” Molecular Autism 13 (1): 1–17. doi:10.1186/s13229-021-00481-3.